Lungcast By cover art

Lungcast

By: American Lung Association & HCPLive
Listen for free

  • Summary

  • Join the American Lung Association and HCPLive every month as Dr. Al Rizzo interviews world-leading experts on the great challenges, accomplishments, and stories in respiratory medicine. Get the latest lung health news, including future Lungcast topics and guests, by signing up for our newsletter at Lung.org. (https://www.lung.org)
    Show more Show less
Episodes
  • 2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes

    2024 State of the Air: Record Highs in US Particle Pollution, with Dr. John Balmes
    Apr 24 2024
    Episode Highlights
    0:16 Intro
    2:17 What caused the particle pollution spike?
    6:28 The health effects of fine particle pollution exposure
    10:23 The new EPA particle pollution standard
    14:27 Improvements to ozone pollution and the Clean Air Act
    18:46 How to advocate for improvement
    20:23 Air quality inequity
    24:03 Reflecting on 25 years, and looking ahead
    25:52 Outro

    Dr. John Balmes, a renowned environmental health sciences expert from the University of California, San Francisco, join Lungcast for a deep dive into the American Lung Association’s newly released 2024 “State of the Air” report. Balmes specifically provides context behind several concerning trends, notably a spike in deadly particle pollution—the highest levels in the past 25 years largely due to wildfires.

    The eye-opening conversation also impresses upon the importance of clean transportation and power generation to help mitigate population-wide risk.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    27 mins
  • Lung Allocation System: Improving Patient Access with Kenneth McCurry, MD & Maryam Valapour, MD, MPP

    Lung Allocation System: Improving Patient Access with Kenneth McCurry, MD & Maryam Valapour, MD, MPP
    Apr 2 2024
    0:16 Intro
    2:28 Recent modifications to the lung allocation score
    5:11 Monitoring chronic graft rejection
    9:23 The rising use of ex vivo lung perfusion
    16:17 The presence of post-COVID patients on the lung transplant waitlist
    21:01 Impact of long Covid on transplant rehabilitation
    22:51 Double lung transplant in bilateral lung cancer—what’s the future?
    26:52 Effect of LAS on lung transplant survival racial disparity
    31:05 What lies ahead in the practice of lung transplantation
    35:00 Outro

    Cleveland Clinic’s Maryam Valapour, MD, MPP, rejoins the broadcast, along with her colleague Kenneth McCurry, MD to discuss optimization of the lung allocation system to continue reducing waitlist times and patient mortality.

    It includes commentary on how recent changes to scoring protocols are expected to impact ongoing disparities related to race and socioeconomic status. They additionally talk about the role of transplantation in patients who have severely damaged lungs resulting from COVID-19 infection, an update since our April 2021 conversation.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    36 mins
  • The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer

    The Promise of Lung Cancer Precision Medicine with Dr. Jonathan Spicer
    Feb 12 2024
    Episode Highlights
    0:15 Intro
    3:09 Low-dose CT screening uptake in Canada
    4:45 Evolution of adjuvant, neoadjuvant therapies
    7:10 Reviewing CheckMate 816
    10:56 Reviewing KEYNOTE-671
    12:58 The impact of neoadjuvants on operability
    16:15 Treatment-specific biomarkers for lung cancer
    21:13 The short-term future of lung cancer therapy
    24:31 Outro

    Precision medicine–delivering the right drug at the right time to the right patient–is the direction in which lung cancer treatment is heading. In this episode, we talk about an exciting, emerging drug class with one of the most prominent investigators involved with its development, Dr. Jonathan Spicer at McGill University’s Thoracic Oncology Network. 

    It provides a deep dive into neoadjuvant therapy for patients who have operable lung cancer, offering insight into what is currently known about response and failure rates.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show more Show less
    26 mins
Physical Illness & Disease Hygiene & Healthy Living Politics & Government Science
Show more Show less

What listeners say about Lungcast

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available